PT  - JOURNAL ARTICLE
AU  - Munish Kumar
AU  - Karthikeyan Subramanian
AU  - Karan Singh Tanwar
AU  - Arun Prabhahar
AU  - Smita Divyaveer
AU  - Ashwani Sood
AU  - Bhagwant Rai Mittal
AU  - Apurva Sood
TI  - Radioiodine therapy in patient of differentiated thyroid cancer with end-stage renal disease on maintenance hemodialysis: case report with review of literature.
AID  - 10.2967/jnmt.121.261979
DP  - 2021 Dec 01
TA  - Journal of Nuclear Medicine Technology
PG  - jnmt.121.261979
4099  - http://tech.snmjournals.org/content/early/2021/12/06/jnmt.121.261979.short
4100  - http://tech.snmjournals.org/content/early/2021/12/06/jnmt.121.261979.full
AB  - Surgical resection followed by radioactive-iodine (131I) therapy constitutes a standard treatment for differentiated thyroid cancer (DTC). 131I is normally excreted through kidneys and treatment of patients with end stage renal disease (ESRD) on hemodialysis requires special attention for dosage of 131I, timing of dialysis and radiation safety. We present a case of a post-thyroidectomy patient with ESRD on haemodialysis who required radioactive iodine ablation with review of literature.